Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 13,444,600 | 14,377,900 | 13,452,900 | 12,273,900 | 11,448,800 |
| Cost of Goods | 1,805,200 | 1,955,400 | 1,816,300 | 1,630,000 | 1,478,700 |
| Gross Profit | 11,639,400 | 12,422,500 | 11,636,600 | 10,643,900 | 9,970,100 |
| Operating Expenses | 6,592,101 | 5,380,301 | 5,748,300 | 5,298,100 | 4,819,100 |
| Operating Income | 5,047,499 | 7,042,600 | 5,888,600 | 5,345,800 | 5,151,700 |
| Other Income | 5,301 | 3,900 | 11,000 | -217,000 | -218,700 |
| Pre-tax Income | 5,052,800 | 7,046,500 | 5,899,600 | 5,128,800 | 4,933,000 |
| Income Tax | 992,300 | 1,158,000 | 1,425,600 | 2,458,700 | 1,237,300 |
| Net Income Continuous | 4,060,500 | 5,888,500 | 4,474,000 | 2,670,100 | 3,695,700 |
| Minority Interests | 59,900 | N/A | 43,300 | 131,000 | -7,100 |
| Net Income | $4,000,600 | $5,888,500 | $4,430,700 | $2,539,100 | $3,702,800 |
| EPS Basic Total Ops | 24.86 | 31.47 | 21.63 | 11.94 | 16.96 |
| EPS Basic Continuous Ops | 25.24 | 31.47 | 21.84 | 12.56 | 16.92 |
| EPS Diluted Total Ops | 24.80 | 31.42 | 21.58 | 11.92 | 16.93 |
| EPS Diluted Continuous Ops | 25.17 | 31.42 | 21.79 | 12.54 | 16.89 |
| EPS Diluted Before Non-Recurring Items | 33.70 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $5,504,699 | $7,723,200 | $6,539,101 | $6,426,801 | $5,834,400 |